IL33 and asthma: Recent studies have demonstrated that type 2 inflammation and indirect airway hyperresponsiveness in asthma are related to a shift in mast cells from the submucosa to the airway epithelium and that mast cells cooperate with epithelial cells through IL‐33 signaling to regulate type 2 inflammation [29, 30].